ArchiMed completes acquisition of Natus Medical Incorporated for $1.2 billion total equity value
Benzinga
JULY 21, 2022
In accordance with the definitive merger agreement, Natus shareholders received $33.50 in cash for each share of Natus common stock. ArchiMed's mix of operational, medical, scientific and financial expertise will help us continue our mission to serve our customers as we internationalize and grow our business," said Thomas J.
40 
Let's personalize your content